@ali_on_t's TRT ancillary claims need more context
Quick answer
The creator is broadly correct that hCG co-administration on TRT serves purposes beyond fertility preservation, specifically maintaining Leydig cell function and intratesticular steroidogenesis. However, the claim that suppressed steroidogenesis causes cardiovascular risk via cholesterol accumulation lacks meaningful clinical support and overstates a minor metabolic pathway. Patients interested in hCG or alternative LH analogs during TRT should discuss the tradeoffs with a licensed provider, including current availability and compounding considerations.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @ali_on_t actually say?
The creator argues that HCG (referred to as "ACG" in the transcript, almost certainly meaning hCG or human chorionic gonadotropin) is not mandatory on TRT but is worth taking even for men who don't care about fertility. The core reasoning: exogenous testosterone shuts down your body's own signaling, which means you stop producing precursor hormones like DHEA and pregnenolone, and that unused cholesterol just "sits in your blood." That's the thesis, and it's more nuanced than most TRT content on this platform.
To be clear about the terminology issue: "Andros" and "Thinere" appear to be garbled transcription of androgens like androstenedione and pregnenolone, which are upstream steroidogenic intermediates. The creator seems to understand the pathway even if the audio didn't capture the names cleanly.
Does the science back this up?
Partially, yes, and more than you'd expect from a TikTok. The steroidogenesis argument is real. When exogenous testosterone suppresses LH and FSH, the Leydig cells in the testes go dormant. Those cells don't just make testosterone, they produce a cascade of steroid precursors including pregnenolone, DHEA, and androstenedione.
A 2013 study by Coviello et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that intratesticular testosterone, maintained by hCG co-administration, is necessary for full spermatogenesis and likely contributes to broader steroidogenic output. Separately, research by Roth et al. (2013, same journal) showed that hCG during TRT preserved intratesticular testosterone concentrations that exogenous T alone could not replicate. The cholesterol claim is shakier. TRT itself is associated with modest changes in lipid panels, but the idea that unused cholesterol "just sits" and causes harm because you're not running it through steroidogenesis is an oversimplification of lipid metabolism.
What did they get wrong (or right)?
They got the steroidogenesis argument broadly right. Suppression of the HPG axis does reduce production of upstream steroid hormones, and hCG can partially restore that by directly stimulating Leydig cells. Credit where it's due: most TRT creators talk only about fertility when discussing hCG, and this creator is correct that the conversation should be wider.
The cholesterol claim is where it gets sloppy. Saying that unused cholesterol "sits in your blood" because you're not converting it to steroid precursors misrepresents how cholesterol is regulated. Hepatic synthesis and dietary intake dwarf the amount used in steroidogenesis. The cholesterol your Leydig cells consume is a rounding error in your total cholesterol pool. Klinefelter and Ewing (1988, Biology of Reproduction) estimated intratesticular cholesterol utilization is a minor fraction of systemic cholesterol metabolism. This claim is not a reason to take hCG, even if the other reasons are solid.
What should you actually know?
If you're on TRT and your doctor hasn't talked to you about hCG or alternatives like enclomiphene, that's a conversation worth having, especially if testicular atrophy bothers you or you have any future fertility considerations. The evidence for hCG maintaining intratesticular testosterone and testicular volume during TRT is reasonably strong.
What the creator doesn't mention: hCG is now predominantly available as a compounded product in the U.S. following FDA actions, which raises its own questions about standardization. Gonadorelin is sometimes offered as an alternative, though the evidence base is thinner. The decision to add any ancillary medication to a TRT protocol should involve a licensed prescriber reviewing your hormone panel, not a TikTok video. This content gets the direction right but should not be used as a clinical decision-making tool.
- hCG co-administration during TRT has real evidence behind it beyond fertility alone
- The cholesterol argument presented here does not hold up to scrutiny
- Talk to your prescriber before adding anything to your protocol
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @ali_on_t's TRT ancillary claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@ali_on_t's TRT ancillary claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator is broadly correct that hCG co-administration on TRT serves purposes beyond fertility preservation, specifically maintaining Leydig cell function and intratesticular steroidogenesis.
FormBlends verdict
The creator is broadly correct that hCG co-administration on TRT serves purposes beyond fertility preservation, specifically maintaining Leydig cell function and intratesticular steroidogenesis. However, the claim that suppressed steroidogenesis causes cardiovascular risk via cholesterol accumulation lacks meaningful clinical support and overstates a minor metabolic pathway. Patients interested in hCG or alternative LH analogs during TRT should discuss the tradeoffs with a licensed provider, including current availability and compounding considerations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is broadly correct that hCG co-administration on TRT serves purposes beyond fertility preservation, specifically maintaining Leydig cell function and intratesticular steroidogenesis. However, the claim that suppressed steroidogenesis causes cardiovascular risk via cholesterol accumulation lacks meaningful clinical support and overstates a minor metabolic pathway. Patients interested in hCG or alternative LH analogs during TRT should discuss the tradeoffs with a licensed provider, including current availability and compounding considerations.
- hCG co-administration during TRT preserves intratesticular testosterone at levels exogenous T alone cannot achieve, per Roth et al. 2013 in JCEM
- LH suppression from TRT does reduce upstream steroid precursor production including DHEA and pregnenolone, making the steroidogenesis argument scientifically grounded
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- hCG co-administration during TRT preserves intratesticular testosterone at levels exogenous T alone cannot achieve, per Roth et al. 2013 in JCEM
- LH suppression from TRT does reduce upstream steroid precursor production including DHEA and pregnenolone, making the steroidogenesis argument scientifically grounded
- The cholesterol claim in this video is not supported: testicular steroidogenesis accounts for a negligible share of total cholesterol metabolism and suppressing it does not measurably raise serum cholesterol
- hCG in the U.S. is now predominantly compounded following FDA market actions, and patients should discuss sourcing and standardization with their prescriber
- Clinical guidelines from the American Urological Association treat hCG as an option for fertility preservation on TRT, not a routine recommendation for all patients
- Alternatives to hCG such as gonadorelin exist but have a weaker evidence base for maintaining intratesticular testosterone during TRT
- No ancillary medication should be added to a TRT protocol without a prescriber reviewing your current hormone panel and health history
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Ali on T · TikTok creator
70.0K views on this video
There’s many benefits to taking ancillaries on treatment, not just for fertility #LowTestosterone #MensHealth
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Ali on T, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.